Clinical trial
Radiomics: a Prospective Study of Outcome in Lung Cancer
NCT01302626 is registered in ClinicalTrials.gov with Maastricht Radiation Oncology as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Radiomics: a Prospective Study of Outcome in Lung Cancer
- Lead sponsor
- Maastricht Radiation Oncology
- Phase
- Observational
- Overall status
- Completed
- Start date
- March 31, 2010
- Completion date
- March 31, 2014
- Enrollment
- 216 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
lung cancer